Introduction {#s0005}
============

Synapses are highly specialized structures responsible for information\'s flow between neurons. Excitatory or inhibitory neurotransmitters, released from presynaptic nerve endings, bind to selective postsynaptic receptors and transduce biochemical signals into electrical ones. Speed and reliability of synaptic transmission are ensured by scaffold proteins, essential components of postsynaptic densities that, by interacting with the cytoskeleton, guarantee the accurate accumulation of postsynaptic receptors at the right place, anchoring them in precise apposition to the presynaptic release sites. This interaction does provide the physical constraints necessary not only for maintaining receptors at synapses but also for regulating the constant exchange of receptors and scaffolding elements in and out of post-synaptic sites ([@bb0180], [@bb0370], [@bb0455], [@bb0350], [@bb0085], [@bb0395]). Postsynaptic specializations exhibit substantial differences at excitatory and inhibitory synapses. While at excitatory synapses postsynaptic densities (PSDs) are localized on dendritic spines and comprise a dense and rich network of interacting proteins, at inhibitory synapses PSDs are localized mainly on dendritic shafts and on the cell body and are less elaborated ([@bb0460]). However, inhibitory synapses directly impinging onto dendritic spines have been also described ([@bb0060], [@bb0530], [@bb0070], [@bb0545]).

At inhibitory synapses, gephryin is the main scaffold molecule that anchors both glycine (Gly) and GABA~A~ receptors to the subsynaptic cytoskeleton, in precise apposition to the presynaptic release sites. Originally purified in association with Gly receptors by Betz group ([@bb0405]), gephyrin has been extensively characterized from a structural, biochemical and functional point of view, thus leading to a deep, though still incomplete, understanding of its clustering properties and of its impact on inhibitory synaptic transmission and plasticity.

Here, we review how the regulation of gephyrin properties and clustering shapes GABAergic synaptic transmission and tonic GABA~A~-mediated inhibition. We summarize recent technological advancements (including intrabodies) used to silence this scaffold protein with an eye towards the physiological impact of such manipulations. We also overview super-resolution microscopy data concerning the nanoscale distribution of gephyrin and its role in synaptic transmission. We discuss gephyrin dynamics in the framework of inhibitory synaptic plasticity *in vitro* and *in vivo*. Finally, we examine gephyrin dysfunctions in neurodevelopmental and neurodegenerative disorders.

Gephyrin at inhibitory synapses: features, regulations and roles {#s0010}
----------------------------------------------------------------

Gephyrin is a 93-kDa protein initially identified as a tubulin-binding molecule that co-purifies with GlyRs ([@bb0405], [@bb0415], [@bb0220]). In vertebrates gephyrin is structurally organized into an N-terminal G-domain and a C-terminal E-domain connected by a central linker region or C-domain ([@bb0415]). The GPHN gene encoding for gephyrin is highly conserved and exhibits a complex intron-exon structure. The alternative splicing of GPHN leads to several gephyrin splice variants expressed both in neuronal and in non-neuronal tissues ([@bb0420]). The structure of the N- and C-terminal domains of gephyrin is similar to the bacterial proteins MogA and MoeA, involved in the biosynthesis of the molybdenum cofactor (Moco), which is essential for the activity of various metabolically important enzymes such as aldehyde oxidase, xanthine oxidoreductase, and sulfite oxidase, crucial for survival ([@bb0345]). Patients suffering from hereditary Moco deficiency present severe neurological abnormalities, microcephaly, and mental retardation ([@bb0220], [@bb0440]). Moreover, they display symptoms that resemble those seen upon loss of inhibitory neurotransmission, including myoclonus and epileptic seizures ([@bb0560]). Crystal structure studies of gephyrin have revealed that while the G-domain has an intrinsic tendency to trimerize the E-domain to dimerize ([@bb0445], [@bb0470], [@bb0475]). Based on these observations it was initially proposed that the full-length protein, *via* the concomitant utilization of both oligomerization domains, forms a planar hexagonal lattice underneath the synaptic membrane ([@bb0470], [@bb0475]), which exposes a high number of binding sites for the recruitment and clustering of GlyRs and a subset of GABA~A~Rs ([@bb0300], [@bb0335], [@bb0505], [@bb0245], [@bb0045]). Deciphering the mechanism by which gephyrin can accommodate both types of inhibitory receptors has been quite challenging and it is far from being fully understood. These receptors belong to the Cys-loop pentameric ligand-gated ion channel superfamily, and therefore they share a similar structural organization. Each subunit of the receptor complex is composed by a large N-terminal ligand binding domain, followed by four transmembrane (TM) domains, a large intracellular loop connecting TM3 and TM4 and a small C-terminal region ([@bb0325], [@bb0500]). The highly unstructured intracellular loop of the GlyR β subunit and of the GABA~A~Rs α1, α2, α3, α5, β2 and β3 subunits ([@bb0300], [@bb0335], [@bb0505], [@bb0245], [@bb0045]) allows inhibitory receptors binding to a hydrophobic pocket of the gephyrin E domain ([@bb0475], [@bb0215]). Structural studies, validated by mutational and biophysical analyses, further identified specific signature sequences shared by the two types of receptors ([@bb0300]) as well as differences in their binding motifs that underline the diverse affinity and modality of interaction ([@bb0305], [@bb0335], [@bb0505]; [@bb9005]). Moreover it has been recently demonstrated that also specific sequences of the C domain contribute to the formation of the GlyR-gephyrin complex ([@bb9005]). Moreover, atomic force microscopy (AFM) and small-angle X-ray scattering (SAXS), have revealed differences in the folding of the intrinsically unstructured C-domain which may account for the observed conformational variability of gephyrin ([@bb0435]). This feature in turn can influence gephyrin folding plasticity and its ability to affect GABA~A~ and Gly receptor dynamics and stabilization at inhibitory synapses.

Unstructured protein domains are privileged target sites for post-translational modifications such as phosphorylation and, indeed, all known gephyrin phosphorylation sites map to the linker region of gephyrin. Given the documented impact of phosphorylation events on the multimerization of gephyrin it is not surprising that they also affect GABA~A~R dynamics and synaptic stabilization. Extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated phosphorylation of gephyrin at serine 268 (S268) was shown to reduce scaffold size and miniature inhibitory postsynaptic currents (mIPSC) amplitude ([@bb0520]) while blocking glycogen synthase kinase 3β (GSK3β)-dependent phosphorylation of gephyrin at serine 270 significantly increases mIPSC amplitude and frequency ([@bb0515]). Unexpectedly, both phosphorylation events, although promoting opposite effects on synaptic morphology, similarly altered the GABA~A~R diffusion properties ([@bb0030]), further emphasizing the complexity of gephyrin scaffolding regulation.

Gephyrin undergoes additional post-translational modifications including palmitoylation ([@bb0110]), S-nitrosylation ([@bb0105]), acetylation ([@bb0185], [@bb0520]) and SUMOylation ([@bb0150]). Palmitoylation is a process that adds a small lipid tail to surface-exposed cysteine residues, allowing the protein to be anchored at the plasma membrane. Gephyrin palmitoylation is mediated by palmitoyl acyltransferase DHHC-12 and involves Cys212 and Cys284, both residues located in the C-domain ([@bb0110]). Over-expression of this enzyme increases the size of gephyrin clusters and consequently the strength of GABAergic transmission. In contrast, preventing gephyrin palmitoylation leads to non-synaptic mislocalized gephyrin clusters ([@bb0110]). Interestingly, the reduced GABAergic transmission due to the expression of a palmitoylation-deficient gephyrin mutant in the basolateral amygdala leads to severe anxiety disorders in rats ([@bb0450]).

Gephyrin directly interacts with neuronal nitric oxide synthase (nNOS) and it gets physiologically S-nitrosylated, a modification that negatively affects the cluster size and the overall surface expression of synaptic GABA~A~Rs ([@bb0105]).

More recently, [@bb0150] have discovered the existence of a phosphorylation-dependent SUMOylation of gephyrin that competes with its acetylation ([@bb0150]) for regulating its scaffolding properties. These observations place gephyrin at the convergence of several signaling pathways, which may operate with diverse kinetics in different subcellular localizations, neuronal microcircuits and/or brain regions.

By interacting with different proteins, gephyrin further contributes to regulate synapse formation and plasticity. Gephyrin interactors, including tubulin ([@bb0250]), neuroligin2 (NLG2, [@bb0410]), collybistin ([@bb0380]), the peptidyl--prolyl cis--trans isomerase NIMA-interacting protein1 PIN1 ([@bb0010]), the translation regulator rapamycin and RAFT1 ([@bb0430]), the actin-associated proteins such as Profilin1 and 2, the mammalian enabled (Mena)/vasodilator stimulated phosphoprotein (VASP) ([@bb0160]) and IQSEC3 ([@bb0525]) have been extensively reviewed ([@bb0510], [@bb0575], [@bb0080], [@bb0075]). Interestingly, for some of these interactors, phosphorylation controls their ability to be recruited by gephyrin. One example is given by neuroligin1 (NLG1), the cell adhesion molecule enriched at glutamatergic synapses ([@bb0540], [@bb0155]) which shares, with all NLG family members, the presence of a gephyrin-binding module (GBD) in its intracellular domain and therefore is potentially able to enroll gephyrin at excitatory synapses. Phosphorylation of Tyrosine (Tyr) 782 embedded in the GBD of NLG1, promoted by neurexin-adhesion signaling, was shown to preclude NLG1/gephyrin interaction while favoring PSD-95 recruitment. Such a ligand-induced phospho-tyrosine "switch" could represent a very sensitive mechanism in synaptogenesis, when early neuronal contacts, relying on neurexin/neuroligin adhesion, may be primed to assemble functional inhibitory *vs* excitatory synapses.

It is worth mentioning that in *in vitro* hippocampal neurons subjected to transient oxygen--glucose deprivation or ischemic damage, activation of a calpain-dependent gephyrin cleavage by oxytotoxic stimulation leads to the production of truncated forms of gephyrin with consequent reduction of GABA~A~ receptors clustering and downregulation of GABAergic synaptic transmission ([@bb0090]).

Some synapse do not require gephyrin as an essential player for GABA~A~Rs accumulation, as suggested by GABA~A~Rs subunit specific clustering observed in the absence of gephyrin (gephyrin KO mice) ([@bb0135], [@bb0235]). Those pieces of evidence suggest the involvement of other GABA~A~R clustering proteins. For instance, the dystrophin--glycoprotein complex ensures α1-containing GABA~A~ receptor clustering in a subset of GABAergic synapses in cortical neurons and cerebellar Purkinje cells ([@bb0375]). In cortical and hippocampal neurons in culture, the scaffold protein GIT1 interacts with βPIX to anchor synaptic GABA~A~ receptors and tunes synaptic strength in a gephyrin-independent manner ([@bb0465]). Recently, the tetraspanin LH4 protein, a member of the GARLHs auxiliary subunits, also known as LHFPL4, has been reported to mediate a cell-type specific anchoring of GABA~A~ receptors by forming a stable complex with GABA~A~R γ2 subunit and NLG2 ([@bb0100], [@bb0315], [@bb0555]).

Synaptic distribution of gephyrin at the nanoscale level {#s0015}
--------------------------------------------------------

When visualized with epifluorescence microscopy, gephyrin postsynaptic clusters appear as round-shaped and rather uniform structures. However, the use of super-resolution microscopy allowing sub-diffraction limit spatial resolution (25--30 nm) revealed that the distribution of gephyrin in the postsynaptic area is considerably inhomogeneous, indicating that the gephyrin lattice is a dynamic puzzle of gephyrin nano-domains of different size and density ([@bb0485], [@bb0390], [@bb0480]). Indeed, whereas some synapses show continuous and uniformly distributed gephyrin puncta (single-spot synapses), other synapses exhibit unevenly distributed gephyrin localizations segmented into nano-domains (multi-spot synapses) ([@bb0485], [@bb0390]; [Fig. 1](#f0005){ref-type="fig"}A, B).Fig. 1**Gephyrin at the nanoscale level**. (**A**) Wide-field (left) and photoactivated localization microscopy (PALM, right) of the same dendritic portion of a hippocampal neuron expressing gephyrin-mEos3.2 and immunoprobed for vGAT to localize inhibitory synapse (arrowheads). vGAT immunoreactivity is not shown on the right. Scale bar 1 μm. (**B**) Nanoscale organization of synaptic gephyrin in single-spot (Gaussian, left) and multi-spot (nano-domains, right) clusters. Scale bar, 100 nm. (**C**) Top, Schematized examples of Gaussian and nano-domains organization of the inhibitory postsynaptic disk. Bottom, During iLTP, the fraction of synapses exhibiting gephyrin nano-domains is increased. (**D**) Impact of synapse nanofragmentation during iLTP on simulated IPSC variability. \[Modified from [@bb0390]\].Fig. 1

These findings are in line with electron microscopy studies demonstrating that, at symmetric inhibitory synapses, the postsynaptic density (PSD) can be fragmented ([@bb0280]). Super resolution investigations have also allowed the quantitative characterization of gephyrin clusters at inhibitory synapses. It has been estimated that in cultured spinal cord and hippocampal neurons the size of synaptic gephyrin clusters is \~ 0.04--0.05 mm^2^ ([@bb0485], [@bb0390], [@bb0030]), containing \~ 200--300 gephyrin molecules ([@bb0485], [@bb0385], [@bb0030]). However, the number of gephyrin molecules quantified *in vivo* at spinal cord inhibitory synapses was \~ 600 ([@bb0485]). This discrepancy might be ascribed to a slower maturation of spinal cord neurons in culture as compared to *in vivo* conditions ([@bb0485]). In contrast, *in vivo* cortical inhibitory synapses displayed \~ 130 molecules of gephyrin, hence emphasizing a considerable variability in the abundance of gephyrin molecules among synapses in different neuronal subtypes. Interestingly, at the nanoscale level, clusters of GABA~A~ receptor are spatially correlated with those of gephyrin ([@bb0485], [@bb0095]), thus confirming a close interaction and an architectural interdependence between these synaptic components. The number of GABA~A~ receptors at inhibitory central synapses has been estimated in the range from tens to few hundreds ([@bb9000]). Although it seems that GABA~A~ receptors bind gephyrin trimeric complexes, the exact stoichiometry of GABA~A~ receptors-gephyrin interactions is not fully clarified yet. This lack of knowledge precludes the estimation of the nominal occupancy of gephyrin binding sites by GABA~A~ receptors, as it has been already done for GlyR (\~ 50%) ([@bb0385], [@bb0480]). Additionally, at spinal cord synapses, the scenario would be further complicated by the competition between GABA~A~ receptors and Gly receptors for gephyrin binding sites ([@bb0485]).

By using both electron microscopy and super-resolution approaches, it has been shown that the expression of inhibitory long-term synaptic potentiation (iLTP), induced by either oxygen--glucose deprivation or brief NMDA applications, was accompanied by the relative increase of multi-spot synapses with respect to the single-spot ones, indicating that the increase of synaptic gephyrin during iLTP is associated with gephyrin fragmentation ([@bb0280], [@bb0390]; [Fig. 1](#f0005){ref-type="fig"}C). Recently, a three-color super-resolution approach allowed to resolve the nanoscale organization of the inhibitory synapse, whereby gephyrin, GABA~A~Rs and the active-zone protein RIM (Rab-3 interacting molecule) are arranged in nanodomains ([@bb0095]). In line with the enhanced nano-fragmentation of gephyrin previously observed during inhibitory synaptic potentiation ([@bb0390]), [@bb0095] show an activity-dependent recruitment of additional gephyrin-GABA~A~Rs-RIM nanodomains at inhibitory synapses. However, the molecular mechanisms leading to gephyrin nanoscale rearrangements and the functional role of nano-domains remain elusive. A first attempt to address the latter point exploited a computer model simulation approach to study simulated inhibitory unitary synaptic currents in relation to the GABA~A~Rs compaction within the postsynaptic disk ([@bb0390]; [Fig. 1](#f0005){ref-type="fig"}D). In the case of GABA~A~R compartmentalized in nano-domains, simulated IPSCs showed a lower trial-to-trial variability with respect to a condition whereby synaptic GABA~A~Rs were uniformly diffused in the postsynaptic disk. In the light of the increased fragmentation of the inhibitory PSD during inhibitory synaptic potentiation, those data suggest that iLTP expression may involve a reduction of the inhibitory unitary current fluctuations besides the already known increase of synaptic current amplitude.

Recently, the impact of plasticity-related manipulations of gephyrin phosphorylation (known to modulate gephyrin clusters size) has been studied at the nanoscale level ([@bb0030]). Clusters of phosphomimetic gephyrin mutants were smaller and exhibited higher molecule density as compared to wild types, indicating that gephyrin compaction, controlled by gephyrin phosphorylation, may be an additional determinant for the inhibitory PSD architecture. Overall, at nanoscale level, the postsynaptic structure of GABAergic synapses appears more difficult to predict than that of glycinergic synapses (which shows high affinity gephyrin-GlyR interactions) ([@bb0300]; [@bb9005]) or that of glutamatergic synapses (which shows modular PDZ domain architecture) ([@bb0285]). Nevertheless, GABAergic synapses share with glutamatergic synapses the nanoscale coordination between presynaptic and postsynaptic structural elements ([@bb0290], [@bb0095]) and a nanoscale rearrangement during the expression of synaptic plasticity ([@bb0340],; [@bb0170], [@bb0200], [@bb0495], [@bb0025]). Although the functional role of synaptic proteins nano-compartmentalization is only beginning to be deciphered ([@bb0390]), current data suggest that the coordination of synaptic elements at the nanoscale level represents a fundamental determinant for synaptic plasticity. Future work aimed at analyzing the synaptic dynamics at single molecule level is expected to provide novel and more integrated insights of the principles that regulate the size, the organization and the function of synapses.

Functional role of gephyrin on GABA~A~-mediated postsynaptic currents {#s0020}
---------------------------------------------------------------------

Assessing the functional role of gephyrin on synaptic transmission has been made difficult by the fact that gephyrin knock-out mice die at birth due to breathing failure ([@bb0130]). Therefore, a number of molecular tools have been used to hamper gephyrin function, thus allowing to investigate its functional role in inhibitory synaptic transmission. These include small hairpin RNAs or microRNAs targeting gephyrin mRNA, or intracellular antibody domains (intrabodies) targeting gephyrin at the protein level.

Small hairpin RNAs (shRNAs) have been used to knock-down gephyrin at both GABAergic and glycinergic synapses. Hippocampal neurons in culture, treated with shRNA against gephyrin exhibited a decreased number of synaptic GABA~A~R clusters while leaving their total number unchanged ([@bb0205]). In line with these findings, a decrease in amplitude and frequency of spontaneous GABAergic synaptic currents was observed upon disruption of gephyrin clusters ([@bb0565]). However, no changes in amplitude of currents induced by direct application of GABA were detected, suggesting a selective effect on postsynaptic GABA~A~ receptor clusters. In spinal cord neurons in culture, reducing gephyrin levels with a phosphorothioated gephyrin antisense oligonucleotide, caused a reduction in both amplitude and frequency of miniature glycinergic currents while in the same neurons, only the frequency but not the amplitude of miniature GABAergic currents was affected ([@bb0535]). Blockade of gephyrin expression resulted in synaptic GABA~A~ receptors becoming highly sensitive to zinc and insensitive to benzodiazepines, suggesting that gephyrin is required for the insertion and stabilization of GABA~A~R clusters containing the γ2 subunit.

A strong reduction in gephyrin levels (more than 90%) was obtained also by expressing, in organotypic hippocampal slices, a micro-RNA directed against the mRNA coding for this protein. This produced a reduction in amplitude of inhibitory postsynaptic currents (IPSCs), evoked in CA1 principal cells by stimulation of parvalbumin- and somatostatin-positive GABAergic interneurons ([@bb0355], [@bb0195]). It must be noted that microRNAs might have pleiotropic effects, because each microRNA intrinsically targets a large number of diverse mRNAs.

Hampering protein function at post-translational level may represent an attractive alternative for interfering with gephyrin function in a more spatially localized manner.

One strategy to achieve post-translational protein silencing is provided by the intracellular antibody (intrabody) approach ([@bb0035]), which is recently emerging as a unique strategy to tackle the complexities of protein interaction networks such as that involving gephyrin ([@bb0055]). In this approach, small recombinant antibody domains selected to bind the target protein can be equipped with various signals to achieve a protein retargeting, with fluorescent moieties for live imaging purposes or with effector functions to achieve the targeted degradation of the protein ([@bb0165]; [@bb0320]).

The Intracellular Antibodies Capture Technology (IATC, [@bb0550]) has been used to efficiently and selectively remove gephyrin from Gly and GABA~A~R clusters by providing an anti-gephyrin single-chain antibody fragment (scFv) of a nuclear localization signal ([@bb0570]; [Fig. 2](#f0010){ref-type="fig"}).Fig. 2**Gephyrin declusterization impairs GABAergic synaptic transmission**. **(A)** The intrabody against gephyrin (ScFv-gephyrin) binds the C-domain of gephyrin (aa 153--348). GFP: green fluorescent protein; N: nuclear localization signal; V~H~: intrabody heavy chain; V~L~: intrabody light chain: **(B)** At inhibitory synapses located mainly on dendritic shafts, the scaffold protein gephyrin is responsible for maintaining GABA~A~Rs in front of the presynaptic release sites; gephyrin interacts also with the postsynaptic adhesion molecule neuroligin 2 which binds to its presynaptic partner neurexin to ensure the cross talk between the post and presynaptic specializations. **(C)** ScFv-Gephyrin sequesters gephyrin and retargets it towards the nucleus. Note the reduction in frequency and amplitude of mIPSCs after scFv-gephyrin expression. This may be due to alterations in gephyrin-neuroligin 2 interaction \[Modified from: [@bb0295]\].Fig. 2

When transfected in cultured hippocampal neurons this construct induced a marked decrease in the number of gephyrin clusters associated with a significant reduction in the number of synaptic γ2-subunit containing GABA~A~Rs ([@bb0295]). These effects were associated with a slowdown of the onset kinetics, a reduction in amplitude and in frequency of miniature inhibitory postsynaptic currents.

Interestingly, changes in the onset kinetics, similar to those observed in mice lacking collybistin, a guanine nucleotide exchange factor required for gephyrin-dependent GABA~A~ receptor clustering ([@bb0380]), may be due to modifications in the gating properties of GABA~A~Rs, particularly to a reduced entry into their desensitized state. However, this should be associated with an increase and not a decrease in current amplitude ([@bb0210]). The reduced current amplitude observed by [@bb0295] may result from the concomitant reduction of GABA release from presynaptic GABAergic terminals, in line with the reduced immunoreactivity for vGAT, a vesicular GABA transporter. Moreover, paired recordings from interconnected GABAergic interneurons and principal cells have demonstrated a reduced probability of GABA release, possibly mediated by a trans-synaptic mechanism involving neuroligin 2 ([@bb0540]), an adhesion molecule belonging to the neuroligin family, known to trans-synaptically interact with presynaptic neurexins to ensure the crosstalk between the post- and presynaptic specializations ([@bb0490]). Although the precise mechanism by which gephyrin regulates the gating properties of GABA~A~Rs is still unknown, the possibility that confining receptors into clusters may enhance their allosteric interactions with intracellular proteins (*via* specific domains in the intracellular loop between TM3 and TM4) as suggested for GlyRs ([@bb0255]) cannot be excluded. This would lead to conformational changes and enhanced desensitization, particularly in case of high receptor density. Hampering gephyrin function with scFv induced also a significant reduction of a GABA~A~-mediated tonic conductance, suggesting the involvement not only of synaptic but also extrasynaptic gephyrin clusters ([@bb0295])

More recently, another intrabody-based approach for the post-translational silencing of gephyrin (GFE3) has been developed by fusing an E3 ligase, which mediates the ubiquitination and rapid degradation of proteins, with a recombinant antibody-like protein (FingR) that binds to gephyrin ([@bb0165]). When expressed in dissociated hippocampal neurons GFE3 caused a reduction in frequency and amplitude of mIPSCs ([@bb0165]). Furthermore, in gigantocellular reticular neurons, a dose-dependent reduction in glycinergic synaptic strength was obtained by loading the patch pipette with increasing concentrations of a" super-binding" peptide targeting the intracellular receptor-gephyrin interaction, thus decreasing gephyrin-mediated recruitment of GlyRs at postsynaptic sites ([@bb0310]).

Gephyrin dynamics during synaptic plasticity {#s0025}
--------------------------------------------

GABAergic synapses have been shown to undergo several types of synaptic plasticity expressed at both pre and postsynaptic sites ([@bb0075]). At postsynaptic level, receptor lateral diffusion plays a key role in this process, allowing surface receptors to rapidly exchange between synaptic and extrasynaptic domains ([@bb0085]). Since transient receptor-scaffold interactions govern the "diffusion trapping" of the receptors at postsynaptic sites, changes in the properties, distribution and dynamics of synaptic scaffold proteins are expected to impact into synaptic strength ([@bb0085], [@bb0395]). Indeed, at GABAergic synapses, several studies have shown that, during inhibitory synaptic potentiation, gephyrin accumulation at synaptic sites is enhanced ([@bb0400], [@bb0020], [@bb0140], [@bb0030]), whereas the synaptic dispersal of gephyrin is associated with inhibitory synaptic depression ([@bb0015], [@bb0330], [@bb0360], [@bb0020]). In particular, the dynamics of gephyrin have been studied during the expression of inhibitory long-term potentiation (iLTP) induced by brief NMDA applications ([@bb0400]). Live-cell imaging experiments revealed that during the early phase of iLTP expression (30 min) gephyrin was recruited from extrasynaptic to synaptic sites, indicating that fast gephyrin redistribution between specific sub-neuronal compartments contributes to inhibitory synaptic plasticity ([@bb0400]). Interestingly, simultaneous imaging of GABA~A~R and gephyrin during the expression of this chemically-induced synaptic plasticity showed that gephyrin increase at synapses did not precede the accumulation of GABA~A~Rs, ruling against the hypothesis that GABA~A~Rs require pre-existing synaptic gephyrin in order to be anchored and clustered at synapses. Along the same line, the time course of both GABA~A~R and gephyrin synaptic decrease was studied during the depression of inhibitory synapses induced by the application of 4-aminopyridine ([@bb0360]). This study revealed that the dispersal of GABA~A~Rs preceded that of synaptic gephyrin, indicating that receptors may diffuse away from the synapses independently from gephyrin de-clustering. These studies suggest that while gephyrin is fundamental for the regulation of GABA~A~R mobility and clustering, other scaffold/anchoring proteins are likely to contribute to the rearrangement of the inhibitory PSD both in basal conditions and during the expression of inhibitory synaptic plasticity.

Remarkably, studies tackling the *in vivo* dynamics of gephyrin over days by two-photon imaging of inhibitory synapses, identified by fluorescent markers, revealed that dendritic gephyrin clusters are continuously assembled and disassembled. In layer 2/3 of the mouse visual cortex, dendritic gephyrin puncta imaged at time interval of 4 days exhibited substantial dynamism, with synapses directly impinging onto dendritic spines being significantly more dynamic with respect to those formed onto the dendritic shaft ([@bb0060], [@bb0530]). In the same studies, such basal inhibitory synapse turnover was altered upon the sensory manipulation of the animal ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3**Ocular dominance plasticity induces inhibitory synapses pruning**. **(A)** Ocular dominance (OD) plasticity in adult mouse induces a loss of inhibitory synapses (green spots) from distal dendrites (preferentially innervated by thalamic inputs) in layer 2/3 pyramidal neurons in the visual cortex. **(B)** A representative image of a dendritic portion of a layer 2/3 pyramidal neuron electroporated with cytosolic red fluorescent protein and GFP-gephyrin (green puncta) and imaged *in vivo* at different time points after OD plasticity protocol. Empty arrows indicate the loss of GFP-gephyrin puncta while filled arrows indicate GFP-gephyrin puncta still present. **(C)** Ocular Dominance Index (OD Index) decreases significantly following OD plasticity protocol. \[Modified from [@bb0530]\].Fig. 3

Ocular dominance plasticity induced an increase of inhibitory synapses dynamism, leading to an overall loss of inhibitory inputs that, similar to naïve animals, was more pronounced at inhibitory synapses located at spines ([@bb0060], [@bb0530]). It is worth noting that in layer 2--3 pyramidal cells, spines possessing an inhibitory synapse are preferentially innervated by thalamic inputs ([@bb0530]) and are more likely located in the distal region of apical dendrites ([@bb0060]), thus indicating that these inputs are strategically located in particular sub-neuronal domains in order to absolve to specific dendritic integration and computation functions. In addition, in sub-regions of pyramidal cells dendrites (about 10 μm), synaptic gephyrin puncta dynamics correlated with that of spines, suggesting that dendritic glutamatergic and GABAergic synapses can be locally coordinated in small dendritic portions ([@bb0060]). More recently, the remodeling of excitatory and inhibitory synapses has been studied with daily intervals ([@bb0545]), thus considerably increasing the temporal resolution as compared to previous attempts ([@bb0060], [@bb0530]). By using an analogous experimental approach as described above, the degree of gephyrin synaptic turnover was found to be markedly higher with respect to that measured at 4 days sampling time, revealing that gephyrin puncta, especially those at glutamatergic spines, are among the most dynamic synaptic elements in cortical dendrites. In addition, gephyrin clusters at spines could disappear and reappear in the same location several times, indicating the presence of a reversible GABAergic structural plasticity mechanism that is expected to modulate "on demand" the strength of specific glutamatergic spines. Intriguingly, at doubly-innervated spines where glutamatergic synapses are substantially stable, inhibitory synapses are the most dynamic, thus highlighting a fundamental role of inhibition in the coordinated flexibility of such persistent glutamatergic inputs.

The high dynamism of gephyrin clustering is also emphasized in the mechanisms of GABAergic synapses formation. Indeed, in layer 2--3 pyramidal neurons of developing somatosensory organotypic slices, it has been demonstrated that the focal dendritic photorelease of caged GABA was able to readily induce the formation of gephyrin puncta that subsequently matured in GABAergic synapses ([@bb0365]). Such induction of inhibitory synapse formation was mediated by the depolarizing action of GABA (typically observed in early postnatal age, [@bb0065]) that determined the engagement of L- and T-type voltage-gated calcium channels. This mechanism also occurred *in vivo*, since the optogenetic activation of somatostatin interneurons (SOM-INs) generated the formation of new gephyrin clusters in close vicinity (\< 2 μm) of presynaptic boutons of somatostatin-positive interneurons ([@bb0365]).

Finally, *in vivo* experiments allowed to determine the role of gephyrin in controlling neuronal connectivity involved in motor control. It is known that one of the major roles of inhibitory interneurons in the zebrafish spinal cord is to prevent the co-contraction of opposing muscles by inhibiting contralateral motoneurons ([@bb0190]). In keeping with this, the elimination of endogenous gephyrin from the spinal cord of zebrafish with the GFE3 molecular tool described above, led to motor incoordination, possibly caused by the co-contraction of opposing muscles ([@bb0165]).

Overall these data show that gephyrin clustering is an important substrate of inhibitory synaptic plasticity and that the dynamism of gephyrin clusters is a powerful mechanism in neuronal networks for the selective and versatile tuning of inhibition both in space and time in relation to specific neuronal activity states.

Gephyrin alterations associated with neuropsychiatric and neurodegenerative disorders {#s0030}
-------------------------------------------------------------------------------------

Mutations in GPHN or alterations in protein expression levels have been found in several neuropathological states including neurodevelopmental and neurodegenerative disorders. Using high resolution microarray data from a cohort of 5384 patients with neurodevelopmental disorders, hemizygous microdeletions at chromosome 14q23 (*de novo* or inherited), overlapping GPHN exons 3--5, which encode for the G-domain of gephyrin, were identified in six unrelated subjects affected by Autism Spectrum Disorders (ASDs), schizophrenia or temporal lobe epilepsy ([@bb0275]). Microdeletions in the GPHN exons 2--3 and 5--9, encoding gephyrin G-domain, have been found also in two patients affected by idiopathic generalized epilepsy ([@bb0115]). Deletions in exons 5--9 impair oligomerization and perturb in a dominant-negative manner the formation of gephyrin clusters at GABAergic synapses while those in exons 2--3 cause a frameshift resulting in a premature stop-codon after exon 1. The GPHN hemizygous missense mutation (G375D), found in a patient with a form of epileptic encephalopathy resembling the Dravet\'s syndrome, but lacking the typical mutation in the SCN1A gene, further strengthens the association of GPHN with epilepsy ([@bb0120]). Although properly folded, when expressed in cultured hippocampal neurons, gephyrin G375D led to alterations in gephyrin clusterization with severe impairment of GABAergic synaptic function. The mutated gephyrin did not affect oligomerization, but reduced the binding affinity to GABA~A~ and GlyRs. In addition gephyrin G375D was unable to synthetize the molybdenum cofactor, essential for the activation of MoCo-dependent enzymes.

A reduced expression of gephyrin was found in hippocampal and adjacent cortical tissues collected during surgery from patients affected by drug-resistant forms of temporal lobe epilepsy (TLE, [@bb0125]). A similar downregulation of gephyrin was observed in animal models of TLE, particularly during the acute period ([@bb0125]). Immunohistochemical and western blot analysis of the hippocampus of patients with intractable forms of TLE unveiled four gephyrin splice variants lacking several exons in their G domains with dominant negative effects leading to oligomerization deficits and alterations of GABA~A~ receptors clustering ([@bb0145]). Interestingly, the extensive cell loss occurring in the hilus and in the CA1 region of the hippocampus following seizures induced by ipsilateral injection of kainate, an animal model of TLE, was associated with hypertrophy of granule cells and a marked increase of postsynaptic GABA~A~ receptor clusters ([@bb0240]). GABAergic synapses reorganization in the dentate gyrus was paralleled by overexpression of gephyrin and dystrophin suggesting that these proteins are both involved in postsynaptic clustering of GABA~A~ receptors.

GPHN was among the nine highly penetrant genetic risk loci for schizophrenia ([@bb0260]). Using a statistical approach "Gene Relationships Across Implicated Loci" (GRAIL), GPHN was shown to play a causal role in schizophrenia, on the basis of its functional connections with other risk genes ([@bb0425]).

Regarding neurodegenerative disorders, the analysis of *post mortem* brain tissues from Alzheimer Disease (AD) patients has allowed unveiling a tight association between gephyrin dysfunction and neurodegenerative diseases ([@bb0005]). An abnormal accumulation of gephyrin, co-localized with β-amyloid plaques, was detected in brain samples from AD patients ([@bb0175]). Biochemical and proteomic analysis revealed a shift in gephyrin\'s solubility with accumulation of a lower molecular weight isoform (a product of gephyrin cleavage), and a reduced amount of the full length gephyrin fragment. These modifications may severely alter GABAergic transmission. In keeping with this, an age-dependent decrease of GABAergic currents, associated with a reduction of mRNA and GABA~A~R proteins was found in *Xenopus* oocytes transplanted with cell membranes isolated from temporal cortices of AD patients ([@bb0270]). Biphasic alterations of gephyrin levels have been described in the APPPS1 mouse, an animal model of AD, at different ages ([@bb0225]). While 3-month-old animals exhibit, before plaques formation, an enhanced expression of gephyrin at inhibitory synapses in the CA1 region of the hippocampus and in the dentate gyrus, adult transgenic animals display decreased levels of the scaffold protein in hippocampal areas devoid of amyloid plaques. This is in accordance with the increased activation of genes encoding for synaptic proteins, including those involved in inhibitory synapses organization, observed in AD patients before the onset of cognitive deficits ([@bb0040]). Decreased gephyrin levels were also found in other AD mouse models, namely AD TG2576 and TG-SwDI as compared to matched controls by using western blot analysis ([@bb9010]).

The impairment of gephyrin function common to several neuropsychiatric disorders points to this inhibitory synapse scaffold protein as a possible target for therapeutic interventions.

Open questions and future directions {#s0035}
------------------------------------

Gephyrin is the main organizer of GABA~A~Rs which, upon activation by GABA released from interneurons, exert a powerful control on network excitability and oscillatory behavior crucial for information processing ([@bb0050]; [@bb0230]). GABA~A~Rs can be localized on the soma and on the dendrites of principal cells and interneurons, at synaptic and extrasynaptic sites to regulate phasic and tonic inhibition, respectively, or on presynaptic axon terminals to regulate transmitter release. While, as highlighted in this review, new data on gephyrin structure and distribution at nanoscale level have contributed to better understand its function, many aspects related to its temporal and spatial dynamics during plasticity processes are still largely unknown. Does gephyrin bind to extrasynaptic GABA~A~Rs? Does this scaffold regulate dynamic changes between synaptic and extrasynaptic GABA~A~ receptors particularly during activity-dependent synaptic plasticity processes? How does gephyrin interact with GABA~A~Rs to form synaptic and extrasynaptic clusters early in development, when GABA exerts a depolarizing and excitatory action on its targets?

How, during critical periods of brain development, does gephyrin contribute to experience-dependent re-shaping of neuronal circuits to adapt GABAergic transmission to changing contingencies?

A closer examination of gephyrin function will be essential to answer these open questions. Furthermore, the knowledge of the multifaceted gephyrin roles at inhibitory synapses will help designing new drugs for the treatment of brain disorders caused by dysfunctions of inhibitory synaptic transmission.
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